Pharmaceutical News and Articles

Comprehensive and up-to-date drug news for both consumers and healthcare professionals.

Calorie Labeling of Foods Leads to Small Reduction in Energy Selected

Calorie labeling of food leads to a small reduction in energy selected and consumed, according to a systematic review published online Jan. 17 in the Cochrane D

Most People With Long COVID Do Not Recover in Second Year of Illness

The majority of working-age patients with postacute sequelae of COVID-19 post-COVID-19 syndrome (PCS) do not recover in the second year of their illness, accord

Medical Use of Cannabis Tied to Higher Prevalence of Cannabis Use Disorder

Adults aged 18 to 49 years reporting medical-only or medical-nonmedical cannabis use may have a higher prevalence of cannabis use disorder (CUD) than those repo

Medical Weed Users At Risk for Addiction

People using weed for medical purposes are as likely or more to become addicted to cannabis as recreational tokers, a new study says. Folks using medical mariju

COVID Vaccine Hesitancy Reducing Childhood Vaccinations

Hesitancy over the COVID-19 vaccine is leading some parents to skip important vaccinations for their children. Young children of parents who declined the COVID

Eating Right, Exercising Before Surgery Improves Outcomes

Patients can improve their odds for a successful surgery by actively preparing for the procedure through diet and exercise, a tactic called prehabilitation, a n

Certain Meds and Diet Can Reverse Type 2 Diabetes

People can reverse their type 2 diabetes through a combination of calorie cutting and medication, a small clinical trial says. Overweight and obese adults cause

Does Sleep Apnea Contribute to Car Crashes?

Many major maladies have been linked to disturbed slumber caused by sleep apnea, high blood pressure, heart problems and diabetes. Add car wrecks to that list,

Humanetics Corporation Announces Positive Phase 2 Clinical Trial Results in COVID-19 Study Aimed at Improving Pulmonary Function

Humanetics Corporation (Humanetics) announced today the results of its Phase 2 clinical trial of BIO 300 Oral Suspension (BIO 300) for the mitigation of impaire

Tris Pharma Announces Positive Results from ALLEVIATE-1 Phase 3 Clinical Trial of Cebranopadol, an Investigational First-in-Class Oral Dual-NMR Agonist, for the Treatment of Moderate-to-Severe Acute Pain

MONMOUTH JUNCTION, NJ, January 22, 2025 Tris Pharma, Inc. (Tris), a commercial-stage biopharmaceutical company, today announced positive topline results from it

Popular Keywords